Shenzhen YHLO Biotech Co., Ltd.

Shanghai Stock Exchange 688575.SS

Shenzhen YHLO Biotech Co., Ltd. Free Cash Flow Per Share for the year ending December 31, 2023: USD -0.18

Shenzhen YHLO Biotech Co., Ltd. Free Cash Flow Per Share is USD -0.18 for the year ending December 31, 2023, a -169.96% change year over year. Free cash flow per share is the free cash flow generated per share. Indicates investment potential based on cash flow generation.

Shenzhen YHLO Biotech Co., Ltd. Free Cash Flow Per Share for the year ending December 31, 2022 was USD 0.26, a 931.09% change year over year.
Shenzhen YHLO Biotech Co., Ltd. Free Cash Flow Per Share for the year ending December 31, 2021 was USD -0.03, a -225.19% change year over year.
Shenzhen YHLO Biotech Co., Ltd. Free Cash Flow Per Share for the year ending December 31, 2020 was USD 0.03, a 265.62% change year over year.
Shenzhen YHLO Biotech Co., Ltd. Free Cash Flow Per Share for the year ending December 31, 2019 was USD -0.02, a 67.86% change year over year.

Key data

Date	Free Cash Flow Per Share	Return on Assets (ROA)	Return on Equity (ROE)	Return on Capital Employed (ROCE)

Shanghai Stock Exchange: 688575.SS

Shenzhen YHLO Biotech Co., Ltd.

CEO	Mr. Yongbo Song
IPO Date	May 17, 2021
Location	China
Headquarters	Building 1
Employees	1,759
Sector	Healthcare
Industries Biotechnology 3D Printing Cleaning Supplies Hardware & Electronics Medical Instruments Pharmaceuticals Plastics Vaccines

Description

Shenzhen YHLO Biotech Co., Ltd. engages in developing, manufacturing, and distributing in-vitro diagnostic instruments and reagents in China. It offers clinical solutions for autoimmune, reproductive health, infectious, and other diseases; CLIA test panels, chemiluminescence immunoassay analyzers, and integration systems for immunoassay; ELISA test panels and immune analyzers; LIA test panels, blot analyzers, and line immunoassays; POCT test panels and immunofluorescence readers; ESR Analyzers; and COVID-19 detection kits. The company also exports its COVID-19 detection kits to various countries, including Germany, France, Italy, Denmark, Sweden, etc. Shenzhen YHLO Biotech Co., Ltd. was founded in 2008 and is headquartered in Shenzhen, China.

Key trends

Past 5 years